Invention Grant
- Patent Title: Method for treating hemolytic uremic syndrome
-
Application No.: US15775811Application Date: 2016-11-14
-
Publication No.: US10653657B2Publication Date: 2020-05-19
- Inventor: Ki Young Sohn , Jae Wha Kim
- Applicant: ENZYCHEM LIFESCIENCES CORPORATION
- Applicant Address: KR Seoul
- Assignee: Enzychem Lifesciences Corporation
- Current Assignee: Enzychem Lifesciences Corporation
- Current Assignee Address: KR Seoul
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Peter F. Corless
- International Application: PCT/KR2016/013078 WO 20161114
- International Announcement: WO2017/082709 WO 20170518
- Main IPC: A61K31/231
- IPC: A61K31/231 ; A61P7/06 ; A61P7/00 ; A61P13/12 ; A61K9/48 ; A61K31/739 ; A61K31/138 ; A61K31/675 ; A61K31/7068 ; A61K31/15
Abstract:
The present invention provides methods for treating, controlling or mitigating hemolytic uremic syndrome (HUS), comprising administering a monoacetyldiacylglycerol compound to a patient in need thereof, as well as compositions useful therefor.
Public/Granted literature
- US20180325857A1 METHOD FOR TREATING HEMOLYTIC UREMIC SYNDROME Public/Granted day:2018-11-15
Information query
